A small cap pharma company with a market cap of 3389 cr It is a high cash reserved company.it is in a 3 year breakout
buy@402-410 levels for a tgt of 520.
mkt cap-3389, pe 13.45
sales improved during 2016-2019 is 1344 cr to 1643
net profit improved from 163 cr to 193 cr during 2016-2019
eps improved from 19.16 to 24.11 during 2016-2019.
No comments:
Post a Comment